ANNA VYBORNOVA

Anna has a MSc in bioengineering from EPFL and brings to the team her operational experience in medtech and pharma. She was the first employee of a startup, where she led a team of engineers and doctors to bring a new consumer medical device to the European market. She has published multiple academic papers and holds 2 patents.

Henry has a PhD in medical sciences from the University of Oxford and over the past 5 years has investigated the biology of both HIV and herpes simplex virus. He discovered herpes viruses prevent cGAMP transport. Additionally, he holds a joint honour’s degree in chemistry and brings practical experience and a network within the STI field to the team.

Sam is an award-winning materials scientist and bioengineer, with experience building consumer products and medical devices at Dyson, P&G and several seed to series C startups. He was previously the CEO and cofounder of Biomr, a VC backed deeptech materials startup. He holds a masters degree in Medical Device Design and Entrepreneurship from Imperial College London.

As the Social Media Marketing and Community Building Manager, she supercharges brand awareness, elevates the brand, and helps reach future customers. She co-founded Klub Verboten, which has since become the most highly regarded and respected fetish community in London, Berlin, and Amsterdam. She built a community of over 90,000 people from the ground up and is notorious for knowing practically everyone in sex-positive spaces. A design and content creation rockstar, she understands better than anyone how to market and reach customers in taboo spaces.

Katherine is a multi-disciplinary scientist with experience spanning academia, pharmaceuticals, and biotechnology startups. She received her PhD from the GSK/University of Strathclyde Collaborative PhD Programme, working in medicinal chemistry and chemical biology. Following her PhD, she undertook a POST Fellowship in the Parliamentary Office of Science and Technology, producing a technical briefing document aimed at MPs and peers. She then joined Trio Medicines, where she managed drug development projects ranging from pre-clinical to Phase 2 stages. She moved into the world of startups in 2023, when she joined FabricNano as an Assay Scientist, focusing on the development and validation of business-critical assays for free and immobilised enzymes. She now brings her broad experience and scientific rigour to the Polari team.